Company Profile

RxSight Inc (AKA: Calhoun Vision Inc)
Profile last edited on: 6/9/2024      CAGE: 3PHK6      UEI: J3JCNDYEH4M5

Business Identifier: Medical device company: offering intraocular lens and cataract surgery solutions
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

100 Columbia
Aliso Viejo, CA 92656
   (949) 521-7830
Location: Single
Congr. District: 40
County: Orange

Public Profile

Involving senior personnel from UCSF and Cal Tech - then dba Calchoun Vision - the firm was SBIR-involved with NIH from very shortly after launching. In February 2017 management formally changed the name of the firm to RxSight. Initially self-supporting - the firm was well funded by external sources from 2010, In July 2021, firm went public as NASDAQ:RXST. Structured around addressing the idea of a light adjustable lens (LAL), the power of which could be changed after implantation in the eye by the safe, non-invasive application of light. The first target tackled had been the field of cataract surgery - specifically eliminating refractive errors following intraocular lens implantation. Now headquartered in Aliso Viejo, California. the RxSight mission has been to revolutionize the premium cataract surgery experience - effectively by allowing surgeons to partner with their patients to achieve optimized results for every unique eye. The firm has commercialized the world’s first and only adjustable intraocular lens (IOL) that is customized after cataract surgery: using a proprietary light treatment that produces precise modifications in lens curvature, RxSight’s Light Adjustable Lens (RxLAL™) enables doctors and patients to predictably optimize vision *after* cataract surgery through an office based IOL enhancement.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Publicly Traded
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 1 AF $149,318
Project Title: Machine Aided Contingency Management For Autonomous Operations
2007 2 NIH $1,664,221
Project Title: Adjustable Injectable Intraocular Lens
2007 2 NIH $1,121,465
Project Title: Adjustable Phakic Intraocular Lens
2006 1 NIH $314,233
Project Title: Novel Corneal Implant Materials
2003 2 NIH $856,793
Project Title: Closure Of Retinal Holes With Biodegradable Polymers

Key People / Management

  Matthew Haller -- CEO

  Ron Kurtz -- President & CEO

  Verne Sharma -- President

  Shiao H Chang

  Keith G Duncan

  Rick A Heinick -- Chief Executive Officer and President

  Matt Manning

  John Maynard

  Christian A Sandstedt

  Dan Schwartz -- Founder and Chair

  Eric Weinberg -- Chief Commercial Officer

Company News